These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 9866392)
1. [Clinical picture, course and therapeutic efficiency of pulmonary tuberculosis in patients with organochlorine pesticides and hepatitis B markers]. Mukhtarov DZ Probl Tuberk; 1998; (5):23-4. PubMed ID: 9866392 [TBL] [Abstract][Full Text] [Related]
2. [Detection rate of organochlorine pesticides and viral hepatitis B markers in patients with pulmonary tuberculosis]. Mukhtarov DZ Probl Tuberk; 1998; (1):50-1. PubMed ID: 9553439 [TBL] [Abstract][Full Text] [Related]
3. [Effect of phytotherapy on the prevention and elimination of hepatotoxic responses in patients with pulmonary tuberculosis, carriers of hepatitis B virus markers]. Galitskií LA; Barnaulov OD; Zaretskií BV; Malkov MI; Konenkov SI; Gol'm NP; Tomakov VS; Ogarkov PI; Batskov SS Probl Tuberk; 1997; (4):35-8. PubMed ID: 9333815 [TBL] [Abstract][Full Text] [Related]
4. [Liver morphology in patients with pulmonary tuberculosis with viral hepatitis B and organochlorine pesticides markers]. Mukhtarov DZ; Arifkhanova SI Probl Tuberk; 1997; (1):54-6. PubMed ID: 9162931 [TBL] [Abstract][Full Text] [Related]
5. [Hepatorenal correlations in patients with pulmonary tuberculosis in the presence of viral hepatitis B markers and organic chlorine pesticides: radionuclide studies]. Mukhtarov DZ Probl Tuberk; 2000; (6):47-8. PubMed ID: 11210835 [TBL] [Abstract][Full Text] [Related]
6. [The use of enterosorption in pulmonary tuberculosis patients with side effects from antibacterial preparations]. Cherkasov VA; Dvorianskikh OI Vrach Delo; 1990 Dec; (12):44-6. PubMed ID: 2089798 [TBL] [Abstract][Full Text] [Related]
7. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088 [TBL] [Abstract][Full Text] [Related]
9. Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea. Azzurri A; Kanaujia GV; Sow OY; Bah B; Diallo A; Del Prete G; Gennaro ML Int J Immunopathol Pharmacol; 2006; 19(1):199-208. PubMed ID: 16569358 [TBL] [Abstract][Full Text] [Related]
10. Detection of hepatitis B virus and Mycobacterium tuberculosis in Korean dental patients. Lee SA; Yoo SY; Kay KS; Kook JK J Microbiol; 2004 Sep; 42(3):239-42. PubMed ID: 15459655 [TBL] [Abstract][Full Text] [Related]
11. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases. Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833 [TBL] [Abstract][Full Text] [Related]
12. [Hepatitis B virus infection in tuberculous patients]. Vertun B; Madaliński K; Chrostowski K; Styszewska H Pneumonol Pol; 1978 May; 46(5):329-37. PubMed ID: 673866 [No Abstract] [Full Text] [Related]
13. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series. Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306 [TBL] [Abstract][Full Text] [Related]
14. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection. Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548 [No Abstract] [Full Text] [Related]
15. [Clinical aspects and treatment of destructive pulmonary tuberculosis in patients, carriers of hepatitis B virus]. Shtefanaru LK Probl Tuberk; 1986; (7):40-3. PubMed ID: 3763588 [No Abstract] [Full Text] [Related]
16. [Psychoemotional changes in patients with pulmonary tuberculosis during therapy using psychological and neuropsychological methods]. Strel'tsov VV; Siresina NN; Zolotova NV; Baranova GV; Stolbun IuV; Dolgova IuV; Pankova LI; Erokhin VV; Ergeshov AE; Chernykh NA; Kuz'min AV; Rodina OV; Sel'tsovskiĭ PP Probl Tuberk Bolezn Legk; 2009; (4):31-7. PubMed ID: 19514451 [TBL] [Abstract][Full Text] [Related]
17. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial. Bahrami H; Daryani NE; Haghpanah B; Moayyeri A; Moghadam KF; Mirmomen S; Kamangar F Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of markers of hepatitis B in the adult German population. Jilg W; Hottenträger B; Weinberger K; Schlottmann K; Frick E; Holstege A; Schölmerich J; Palitzsch KD J Med Virol; 2001 Feb; 63(2):96-102. PubMed ID: 11170044 [TBL] [Abstract][Full Text] [Related]
19. [Vaccine prophylaxis of viral hepatitis B in patients with acute leukemia]. Gurina NM; Svedentsov EP; Shardakov VI; Cherepanova VV Ter Arkh; 2008; 80(7):27-9. PubMed ID: 18763590 [TBL] [Abstract][Full Text] [Related]
20. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. Neau D; Winnock M; Galpérine T; Jouvencel AC; Castéra L; Legrand E; Tranchant E; Balestre E; Lacoste D; Ragnaud JM; Dupon M; Lafon ME; Dabis F; HIV Med; 2004 May; 5(3):171-3. PubMed ID: 15139983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]